Free Trial

Randall K. Fields Sells 5,500 Shares of ReposiTrak Inc. (NYSE:TRAK) Stock

ReposiTrak logo with Computer and Technology background

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 5,500 shares of the business's stock in a transaction that occurred on Tuesday, July 8th. The shares were sold at an average price of $19.57, for a total value of $107,635.00. Following the transaction, the chief executive officer owned 147,000 shares of the company's stock, valued at $2,876,790. This trade represents a 3.61% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

ReposiTrak Stock Performance

Shares of TRAK traded up $0.10 during midday trading on Wednesday, hitting $19.74. 22,403 shares of the company's stock traded hands, compared to its average volume of 50,176. ReposiTrak Inc. has a 1 year low of $15.72 and a 1 year high of $25.01. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01. The firm has a market cap of $360.77 million, a PE ratio of 58.06 and a beta of 0.51.

ReposiTrak Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 14th. Stockholders of record on Monday, June 30th will be issued a dividend of $0.0182 per share. The ex-dividend date is Monday, June 30th. This represents a $0.07 annualized dividend and a dividend yield of 0.37%. ReposiTrak's dividend payout ratio is presently 23.53%.

Institutional Trading of ReposiTrak

An institutional investor recently raised its position in ReposiTrak stock. Ellsworth Advisors LLC increased its holdings in shares of ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 31,289 shares of the company's stock after acquiring an additional 2,997 shares during the period. Ellsworth Advisors LLC owned approximately 0.17% of ReposiTrak worth $634,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 27.35% of the company's stock.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded ReposiTrak from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.

Read Our Latest Research Report on TRAK

ReposiTrak Company Profile

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Further Reading

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

Should You Invest $1,000 in ReposiTrak Right Now?

Before you consider ReposiTrak, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.

While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead
3 Made in America Stocks Under $20 You Need to See!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines